NEW YORK (GenomeWeb News) - PerkinElmer has agreed to buy ViaCell, a Cambridge, Mass.-based specialty stem cell company, for around $300 million, the companies said Monday.
 
ViaCell focuses on collecting and preserving umbilical cord blood stem cells, and Perkin Elmer said it expects the acquisition to “significantly expand” its neonatal and prenatal screening business.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Osamu Shimomura, who won the 2008 Nobel Prize in Chemistry for his work on green fluorescent protein, has died.

The US National Institutes of Health has developed guidelines to gauge whether frail chimpanzees are healthy enough to be moved to a retirement sanctuary.

In PLOS this week: analytical approach for finding new genetic associations, analysis of Streptococcus pyogenes-infecting viruses, and more.

Stat News reports that the head of IBM Watson Health is leaving her post.